March 6, 2019. Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the appointment of Dan Furrer as Head of Corporate Marketing. Mr Furrer will lead the new corporate marketing function and in conjunction with corporate medical and commercial teams, plans to build a global marketing centre of excellence for Neuraxpharm. He will report directly to the CEO, Dr. Jörg-Thomas Dierks.
Dan Furrer has over 20 years of experience in building and running marketing operations in the pharmaceutical industry. He joins Neuraxpharm from Mylan where he was Country Manager in the Czech Republic, and Meda Pharma, prior to the acquisition by Mylan, where he was Country Manager for Germany and Switzerland. He was also Country Manager at Spirig Pharma Switzerland and held several positions in marketing, including Head of International Marketing, Marketing & Regional Sales Manager and Product Manager in CNS at different companies.